Novel Pmvs/Zip4/Zinc/Prelamin A Axis Promotes Nuclear Dysmorphism And Vascular Aging In Humans And Rodents Post-Injury: Effective Treatment With Platelet Membrane-Coated ZIF-8 Nanoparticles
When blood vessels are injured, for example during surgery or other medical procedures, they can sometimes develop problems like abnormally shaped cell nuclei and accelerated aging. Recent research has shed light on a key mechanism behind these issues. It turns out that tiny sacs released from platelets, called platelet-derived microvesicles, can attach to injured blood vessels.
Once attached, these microvesicles reduce the amount of zinc inside the vascular smooth muscle cells, which are important for blood vessel structure. This reduction in zinc then hinders an enzyme responsible for processing a protein called prelamin A. As a result, prelamin A accumulates, leading to the cells’ nuclei becoming misshapen (a condition known as nuclear dysmorphism) and contributing to the premature aging of the blood vessels. A specific protein, the zinc transporter ZIP4, was found to be crucial in this process of decreased zinc concentration.
However, there’s promising news. Scientists have developed a novel treatment using nanoparticles, which are incredibly tiny particles, coated with platelet membranes and containing zinc. These “smart” nanoparticles effectively deliver zinc to the affected cells, significantly reducing the nuclear abnormalities and slowing down vascular aging after injury. This discovery not only uncovers a new understanding of how blood vessels age after injury but also offers a potential new therapeutic approach to combat these complications.
Source: link to paper